Navigation Links
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
Date:6/7/2009

ride (8 mg, once daily) in patients with type 2 diabetes. Patients were treated previously with diet/exercise or low doses of one oral antidiabetic drug (OAD). The trial had a 52-week randomized, double-blind period followed by the one-year extension; 59% entered the extension period of the trial and 43% of these patients completed the full two-year study period.

LEAD(TM) 3: two-year data

    Two years                Liraglutide       Liraglutide       Glimepiride
     monotherapy             1.8 mg, QD        1.2 mg, QD        8 mg, QD
                             N=154             N=149             N=137

    Diabetes duration,
     years at baseline         5.0                5.0              5.0

    Previous treatment:
    % diet/exercise             35%                38%              34%
    % OAD monotherapy           65%                62%              66%

    A1C % at baseline          8.1                8.1              8.0

    BMI, kg/m(2) at
     baseline                   33                 33               33

    Change in A1C% from
     baseline                 -1.1               -0.9             -0.6

    Change in A1C%  from
     baseline (in
     patients with <3
     years duration of
     diabetes)                -1.4               -1.1             -0.7

    % A1C <7.0%                 58                 53               37

    Change FPG (Fasting
     Plasma Glucose)
     mg/dL from baseline       -27                -24               -6

    Weight change, kg
     from baseline            -2.7               -2.1              1.1

    Minor hypoglycemic
     events/patient/year      0.23               0.21             1.76

Safety and tolerability of liraglutide

The rate of minor hypoglycemia was statistically significantly lower with both liraglutide dose groups compared to the glimepiride-t
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
2. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
3. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
4. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
5. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
6. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
7. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
8. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
9. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
10. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
11. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 16 Cellular Dynamics International ... of iCell(TM) Cardiomyocytes for use in testing of ... These human heart cells are designed to aid ... compound efficacy and toxicity screens, weeding out ineffective ... pipeline process before significant time and resources have ...
(Date:12/15/2009)... NORCROSS, Ga., Dec. 15 Immucor, Inc. (Nasdaq: ... instrument-reagent systems to the blood transfusion industry, today announced ... earnings on Wednesday, January 6, 2010 after the market ... Thursday, January 7, 2010 at 8:30 a.m. (Eastern Time) ... invited to participate in this conference call by dialing ...
(Date:12/15/2009)... SALT LAKE CITY, Dec. 15 Sonic ... hearing care services and solutions, donated $10,000 to ... on Monday, Dec. 14, 2009. ,, Sonic Innovations ... the local Feeding America member, the Utah Food ... location. Sonic employees also participated in an office ...
Breaking Medicine Technology:Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 2Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 3Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 4Sonic Innovations, Inc. Donates $10,000 to Feeding America 2Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 1Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 2Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 3Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 4Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 5Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 6Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 7Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 8Reportlinker Adds Cell Culture 3A The World Market for Media Sera and Reagents 2nd Edition Report 58012 9FaxSIPit and FaxBack Announce Partnership To Bring Reliable VoIP Fax to Service Providers 58010 1FaxSIPit and FaxBack Announce Partnership To Bring Reliable VoIP Fax to Service Providers 58010 2FaxSIPit and FaxBack Announce Partnership To Bring Reliable VoIP Fax to Service Providers 58010 3TAXUS 28R 29 Liberte 28R 29 Stent Continues to Demonstrate Significant Improvements Over TAXUS 28R 29 Express 28R 29 Stent in Small Vessels and Long L 58007 1TAXUS 28R 29 Liberte 28R 29 Stent Continues to Demonstrate Significant Improvements Over TAXUS 28R 29 Express 28R 29 Stent in Small Vessels and Long L 58007 2TAXUS 28R 29 Liberte 28R 29 Stent Continues to Demonstrate Significant Improvements Over TAXUS 28R 29 Express 28R 29 Stent in Small Vessels and Long L 58007 3TAXUS 28R 29 Liberte 28R 29 Stent Continues to Demonstrate Significant Improvements Over TAXUS 28R 29 Express 28R 29 Stent in Small Vessels and Long L 58007 4TAXUS 28R 29 Liberte 28R 29 Stent Continues to Demonstrate Significant Improvements Over TAXUS 28R 29 Express 28R 29 Stent in Small Vessels and Long L 58007 5
... Progress with VeraTag(TM) Assays in Breast ... Cancer, ... ) today announced five posters to be,presented at the 30th San Antonio Breast ... Following are details for,each embargoed session:, -- Friday, December 14th, 2007, ...
... 7 Ortho Biotech today announced that 12,clinical ... be presented at the 49th annual meeting of ... World Congress Center on December 8-11,2007., "We ... studies for,presentation," said Craig Tendler, M.D., Vice President, ...
Other Medicine Technology:Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 2Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 3Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 2Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 3Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 4Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 5Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 6Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 7Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 8Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 9
(Date:12/16/2009)... and Global Market Expansion , ... Ramat-Gan, Israel (PRWEB) ... Analytics to Web sites and companies, today announced a record year ... Since its launch on July 2008, Kampyle has processed more ... amassed more than 30,000 customers in 191 countries., , ,Kampyle pioneered ...
(Date:12/16/2009)... Tyco International Ltd. (NYSE: ... E. Daniels for election to the Tyco Board ... on March 10, 2010. ,, Daniels, 55, ... Services group of International Business Machines Corporation. In ... Global Services business operations consisting of outsourcing services, ...
(Date:12/16/2009)... 16 Medizone International, Inc. (OTC Bulletin ... of Directors and the Board of Medizone New ... International Inc. holds a 50% interest, agreed on ... and reconvey to Medizone International all global marketing ... International,s Chairman, Edwin G. Marshall said, "Time has ...
(Date:12/16/2009)... the ,70s, study finds , , TUESDAY, Dec. 15 (HealthDay ... United States than it was more than 30 years ... compared National Health and Nutrition Examination Survey data from ... and from 8,339 black and white participants from 1999 ... old. , The prevalence of myopia increased from 25 ...
(Date:12/16/2009)... and appeared on The Amazing Race , , WEDNESDAY, ... of herself as part human, part machine. , A one-legged ... likes to describe herself. When she,s not training for a ... or posing nude with her metal leg crossed over her ... ESPN Body Issue. , She is the first female ...
Breaking Medicine News(10 mins):Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 2Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 3Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 4Health News:Kampyle Experiences Record Growth in 2009 with 25,000 New Customers 5Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4
... increasing at an alarming rate yet a superior, simpler, natural solution ... ... 2008 -- Purported "brain enhancement" drugs such as Ritalin, Modafinil, and ... States during the past decade according to the National Institute of ...
... and Network Services,LLC (MNS) announced today, that it ... MultiPlan, Inc. to become effective December 1, 2008.,Under ... provision of skilled nursing,services to eligible health plan ... Network regionally in Illinois, Indiana, Kentucky and,Ohio. ...
... 8 A mural on a 1,230-foot-long wall,along Madison ... as a new Guinness World Record. The mural was ... Inc. (KIB) and more than 50 local community organizations ... held last May. , ...
... the Faces of Influenza Campaign to Promote Annual Vaccination , ... National Influenza Vaccination Week (December 8-14); Urges Immunization Throughout the ... KANSAS CITY, MO., Dec. 8 Health experts recommend ... U.S. Despite this recommendation, influenza immunization rates fall far short ...
... State Health Foundation, Ford Foundation, New York City Investment Fund, Prudential ... Johnson Foundation Among Investors to Join Leading Advocate for Independent Workers ... of America’s Workforce , ... NEW YORK (Business ...
... from cell death and exerts resistance to chemotherapy has an ... and kill the very tumor cells it usually protects, researchers ... new study published in the Dec. 9 issue of ... called a kinase, that is hyperactive in the majority of ...
Other Medicine News:Health News:Brain Boosting Drugs vs. Walking: Treadmill Desk Manufacturer Promotes Common Sense 2Health News:Brain Boosting Drugs vs. Walking: Treadmill Desk Manufacturer Promotes Common Sense 3Health News:Lilly Global Day of Service Receives National and Local Recognition 2Health News:Lilly Global Day of Service Receives National and Local Recognition 3Health News:The American Lung Association of the Central States Encourages Kansas City Residents to See Themselves Among the Many 'Faces' of Influenza 2Health News:The American Lung Association of the Central States Encourages Kansas City Residents to See Themselves Among the Many 'Faces' of Influenza 3Health News:The American Lung Association of the Central States Encourages Kansas City Residents to See Themselves Among the Many 'Faces' of Influenza 4Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 2Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 3Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 4Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 5Health News:An Achilles heel in cancer cells 2
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Micro emulsifying needles, 18G....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
... forceps "micro 2000", with ... tension light-weight instruments with ... extremely light weight, well ... fatigueless working, easy to ...
Medicine Products: